Effects of m-nisoldipine on the activity and mRNA expression of four CYP isozymes in rats

References

• Antonissen G, Devreese M, Baere SD, et al. (2017). Impact of Fusarium mycotoxins on hepatic and intestinal mRNA expression of cytochrome P450 enzymes and drug transporters, and on the pharmacokinetics of oral enrofloxacin in broiler chickens. Food Chem Toxicol 101:75–83
   PubMed Web of Science ®Google Scholar
• Bahadur S, Mukherjee PK, Pandit S, et al. (2016). Herb-drug interaction potential of Berberis aristata through cytochrome P450 inhibition assay. Synergy 4:1–7
   Google Scholar
• Caballero MV, Ares I, Martínez M, et al. (2015). Fipronil induces CYP isoforms in rats. Food Chem Toxicol 83:215–21
   PubMed Web of Science ®Google Scholar
• Carter BL, Lund BC, Hayase N, Chrischilles E. (2002). The extent of potential antihypertensive drug interactions in a Medicaid population. Am J Hypertens 15:953–7
   PubMed Web of Science ®Google Scholar
• Chen X, Liu H, Pan Z, et al. (2012). The inhibitory effects of m-nisoldipine on the 5-hydroxytryptamine-induced proliferation of pulmonary artery smooth muscle cells via Ca 2+ antagonism and antioxidant mechanisms. Eur J Pharmacol 686:32–40
   PubMed Web of Science ®Google Scholar
• Cheng Y, Liang X, Feng L, et al. (2016). Effects of phillyrin and forsythoside A on rat cytochrome P450 activities in vivo and in vitro. Xenobiotica 47:297–303
   PubMed Web of Science ®Google Scholar
• Danielson PB. (2002). The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metabol 3:561–97
   PubMed Web of Science ®Google Scholar
• Han YL, Li D, Ren B, et al. (2012). Evaluation of impact of Herba Erigerontis injection, a Chinese herbal prescription, on rat hepatic cytochrome P450 enzymes by cocktail probe drugs. J Ethnopharmacol 139:104–9
   PubMed Web of Science ®Google Scholar
• He XM, Zhou Y, Xu MZ, et al. (2015). Effects of long-term smoking on the activity and mRNA expression of CYP isozymes in rats. J Thorac Dis 7:1725–31
   PubMed Web of Science ®Google Scholar
• Huang Y, Zheng SL, Zhu HY, et al. (2014). Effects of aescin on cytochrome P450 enzymes in rats. J Ethnopharmacol 151:583–90
   PubMed Web of Science ®Google Scholar
• Konno Y, Nemoto K, Degawa M. (2003). Induction of hepatic cytochrome P450s responsible for the metabolism of xenobiotics by nicardipine and other calcium channel antagonists in the male rat. Xenobiotica 33:119–29
   PubMed Web of Science ®Google Scholar
• Konno Y, Sekimoto M, Nemoto K, Degawa M. (2004). Sex difference in induction of hepatic CYP2B and CYP3A subfamily enzymes by nicardipine and nifedipine in rats. Toxicol Appl Pharmacol 196:20–8
   PubMed Web of Science ®Google Scholar
• Li M, Yuan L, Li X, et al. (2013). Studies on separation and pharmacokinetics of m-nisoldipine enantiomers in beagle dog plasma by LC/MS/MS. J Pharm Biomed Anal 85:61–6
   PubMed Web of Science ®Google Scholar
• Miyajima S, Nemoto K, Sekimoto M, et al. (2007). Induction of hepatic cytochrome P450 isoforms by nicardipine at therapeutic doses in spontaneously hypertensive rats. J Toxicol Sci 32:79–90
   PubMedGoogle Scholar
• Pascussi JM, Gerbal-Chaloin S, Drocourt L, et al. (2003). The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 1619:243–53
   PubMed Web of Science ®Google Scholar
• Ramakrishna R, Bhateria M, Singh R, Bhatta RS. (2016). Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes. J Steroid Biochem Mol Biol 163:183–92
   PubMed Web of Science ®Google Scholar
• Rodeiro I, Donato MT, Lahoz A, et al. (2008). Modulation of P450 enzymes by cuban natural products rich in polyphenolic compounds in rat hepatocytes. Chem Biol Interact 172:1–10
   PubMed Web of Science ®Google Scholar
• Sadler NC, Nandhikonda P, Webb-Robertson BJ, et al. (2016). Hepatic cytochrome P450 activity, abundance, and expression throughout human development. Drug Metabol Dispos 44:984–91
   PubMed Web of Science ®Google Scholar
• Spaggiari D, Geiser L, Daali Y, Rudaz S. (2014). A cocktail approach for assessing the in vitro activity of human cytochrome P450s: an overview of current methodologies. J Pharm Biomed Anal 101:221–37
   PubMed Web of Science ®Google Scholar
• Sun Y, Jia P, Yuan L, et al. (2015). Investigating the in vitro stereoselective metabolism of m-nisoldipine enantiomers: characterization of metabolites and cytochrome P450 isoforms involved. Biomed Chromatogr 29:1893–900
   PubMed Web of Science ®Google Scholar
• Tao Z, Wei D. (2015). Recent progress on structural bioinformatics research of cytochrome P450 and its impact on drug discovery. Adv Exp Med Biol 827:327–39
   PubMed Web of Science ®Google Scholar
• Xu RA, Xu ZS, Ge RS. (2014). Effects of hydroxysafflor yellow A on the activity and mRNA expression of four CYP isozymes in rats. J Ethnopharmacol 151:1141–6
   PubMed Web of Science ®Google Scholar
• Yang C, Ren T, Wang J, et al. (2013). Thermodynamic stability analysis of m-nisoldipine polymorphs. J Chem Thermodyn 58:300–6
   Web of Science ®Google Scholar
• Yoon YJ, Kim KB, Kim H, et al. (2007). Characterization of benidipine and its enantiomers' metabolism by human liver cytochrome P450 enzymes. Drug Metabol Dispos 35:1518–24
   PubMed Web of Science ®Google Scholar
• Yuan L, Jia P, Sun Y, et al. (2014). Study of in vitro metabolism of m-nisoldipine in human liver microsomes and recombinant cytochrome P450 enzymes by liquid chromatography-mass spectrometry. J Pharm Biomed Anal 97:65–71
   PubMed Web of Science ®Google Scholar
• Zanger UM, Schwab M. (2013). Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Therapeut 138:103–41
   PubMed Web of Science ®Google Scholar
• Zhang JG, Dehal SS, Ho T, et al. (2006). Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81. Drug Metabol Dispos 34:734–7
   PubMed Web of Science ®Google Scholar
• Zhang YW, Bao MH, Hu L, et al. (2014). Dose-response of oridonin on hepatic cytochromes P450 mRNA expression and activities in mice. J Ethnopharmacol 155:714–20
   PubMed Web of Science ®Google Scholar